Epidemiology, risk factors and screening for melanoma;Épidémiologie, facteurs de risque et dépistage du mélanome

Louvain Medical

Volumn 126, Issue 6, 2007, Pages 190-200

  Tromme, I ^a   Richez, P ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; HUMAN; MELANOMA; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 34547595747     PISSN: 00246956     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Lens MB, Dawes M: Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004; 150: 179-185.
2. Souques M : Probabilité de développer un mélanome sur l'ensemble d'une vie en Ile-de-France en 1994. Ann Dermatol Venereol. 1999 ; 126 : 327-30.
3. de Vries E, Bray FI, Coebergh JW, Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer. 2003 ; 107: 119-26.
4. Bataille V : Génétique et épidémiologie du mélanome. Ann Dermatol Venereal. 2006 ;133: 56-62.
5. Titus-Ernstoff L, Perry AE, Spencer SK et al.: Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol. 2006; 142: 433-8.
6. Doubrovsky A, Menzies SW: Enhanced survival in patients with multiple primary melanoma. Arch Dermatol. 2003; 139: 1013-18.
7. Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J.,Bergman W: Multiple primary melanomas. J Am Acad Dermatol. 2001; 44:22-27.
8. Savoia P, Quaglino P, Verrone A, Bernengo MG: Multiple primary melanomas: analysis of 49 cases. Melanoma Research. 1998; 8: 361-6.
9. Avril MF: Clinical aspects of cutaneous melanoma : atlas. Rev Prat. 2004; 54: 1187-92.
10. Hemminki K, Zhang H, Czene K: Familial and typicable risks in cutaneus melanoma: effects of proband and age. J Invest Dermatol. 2003; 120: 217-23.
11. Bataille V, Hiles R, Bishop JA: Retinobastoma, melanoma and the atypical mole syndrome. Br J Dermatol.1995;132:134-8.
12. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, Melchi CF: Meta-analysis of risk factors for cutaneous melanoma: I. Common and typical naevi. Eur J Cancer ; 41:28-44.
13. Bataille V, Bishop JA, Sasieni P, Swerdlow AJ, Pinney E, Griffiths K, Cuzick J: Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer. 1996; 73(12):1605- 11.
14. Wang TS, Johnson TM, Cascade PN, Redman BG, Sondak VK, Schwartz JL: Evaluation of staging chest radiographs and serum lactate deshydrogenase for localized melanoma. J Am Acad Dermatol. 2004; 51: 399-405.
15. Slade J, Marghoob AA, Salopek TG, Rigel DS, Kopf AW, Bart RS: A typical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol. 1995; 32: 479-94.
16. Autier P: Perspectives in melanoma prevention : the case of sunbeds. Eur J Cancer. 2004 ; 40: 2367-76.
17. Autier P, Dore JF, Lejeune F, Koelmel KF, Geffeler O, Hille P et al.: Recreational exposure to sunlight and lack of information as risk factors for cutaneous malignant melanoma. Results of an European Organization for Research and Treatment of Cancer (EORTC) case control in Belgium, France and Germany. The EORTC Malignant Melanoma Cooperative Group. Melanoma Res. 1994 ; 4: 79-85.
18. Walter SD, King WD, Marrett LD: Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol.1999; 28: 418-27.
19. Autier P, Dore JF, Reis AC, Grivegnee A, Ollivaud L, Truchetet F et al.: Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double-blind randomized trial using personal dosimeters. Br J Cancer. 2000; 83: 1243-8.
20. Autier P, Dore JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj F et al.: Sunscreen use, wearing clothes, and number of nevi in 6-to7-year-old European children. European Organization for Research and Treatment of cancer Melanoma Cooperative Group. J Natl Cancer Inst. 1998;16; 90: 1873-80.
21. Krengel S, Hauschild A, Schafer T: Melanoma risk in congenital melanocytic naevi: a systemic review. Br J Dermatol. 2006; 155: 1-8.
22. Tannous ZS, Mihm MC Jr, Sober AJ, Duncan LM: Congenital melanocyte nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005; 52: 197-203.
23. Watt AJ, Kotsis SV, Chung KC: Risk of melanoma arising in large congenital melanocyte nevi: a systematic review. Plast Reconstr Surg. 2004; 113: 1968-74.
24. Leveque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B et al.: Melanoma in organ transplant patients. Ann Dermatol Venereol. 2000; 127: 160-5.
25. O'Meara AT, Cress R, Xing G, Danielsen B, Smith LH: Malignant melanoma in pregnancy. A population-based evaluation. Cancer. 2005; 103:1217-26.
26. Wiggins CL, Berwick M, Bishop JA: Malignant melanoma in pregnancy. Obstet Gynecol Clin North Am. 2005 ; 32 : 559-68.
27. Silipo V, De Simone P, Mariani G, Buccini P, Ferrari A, Catricala C : Malignant melanoma and pregnancy. Melanoma Res. 2006 ; 16 : 497-500.
28. Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ: Pregnancy and early-stage melanoma. Cancer. 2003; 97: 2248-53.
29. Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP: Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol. 2005; 141: 1032-4.
30. Bafounta ML, Beauchet A, Aegerter P, Saiag P: Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol. 2001; 137:1343-5.
31. Kittler H, Pehamberger H, Wolff K, Binder M: Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002; 3: 159-65.
32. Piccolo D, Ferrari A, Peris K, Diadone R, Ruggeri B, Chimenti S: Dermoscopic diagnosis by a trained clinician vs. A clinican with minimal dermoscopy training vs. Computer-aided diagnosis of 341 pigmented skin lesions: a comparative study. Br J Dermatol. 2002 ; 147:481-6.
33. Henning JS, Dusza SW, Wang SQ, et al.: The CASH (color, architecture, symmetry,and homogeneity) algorithm for dermoscopy. J Am Acad Dermatol. 2007; 56:45-52.
34. Carli P, de Giorgi V, Chiarugi A, Nordini P, Weinstock MA, Crocetti E et al.: Addition of dermoscopy to conventional naked-eye exmination in melanoma screening: a randomized study. J Am Acad Dermatol. 2004; 50: 683-9.
35. Bauer J, Blum U, Strohhävker U, Garbe C: Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy. Br J Dermatol. 2005; 152: 87-92.
36. Carli P, De Giorgi V, Chiarugi A, Nardini P, Weinstock MA, Crocetti E et al.: Addition of dermoscopy to conventional naked-eye examination in melanoma screening : a randomized study. J Am Acad Dermatol. 2004; 50: 683-89.
37. Menzies SW, Gutenev A, Avramidis M, Batrac A, McCarthy WH: Short-term digital surface microscopic monitoring of atypical or changing melanocytic lesions. Arch Dermatol. 2001; 137:1583-89.
38. Kittler H, Pehamberger H, Wolff K, Binder M: Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi. J Am Acad Dermatol.2000; 43: 467-76.
39. Malvehy J, Puig S: Follow-up of melanocytic Skin lesions with Digital Total-Body Photography and Digital Dermoscopy: A Two-Step Method. Clinics in Dermatology. 2002; 20:297-304.
40. Skvara H, Teban L, Fiebiger M, Binder M, Kittler H: Limitations of Dermoscopy in the Recognition of Melanoma. Arch Dermatol. 2005; 141: 155-160.
41. Haenssle HA, Krueger U, Vente C, Thoms KM, Bertsch HP, Zutt M et al.: Results from an Observational Trial : Digital Epiluminescence Microscopy Follow-Up of Atypical Nevi Increases the Sensitivity and the Chance of success of Conventional Dermoscopy in Detecting Melanoma. J Invest Dermatol. 2006; 126: 980-85.
42. Robinson JK, Nickoloff BJ: Digital epiluminescence microscopy monitoring of high-risk patients. Arch Dermatol. 2004; 140: 49-56.
43. Kittler H, Binder M: Risks and benefits of sequential imaging of melanocytic skin lesions in patients with multiple atypical nevi. Arch Dermatol. 2001; 137: 1590-95.